Whetstone Capital Advisors LLC Raises Stock Position in LifeMD, Inc. $LFMD

Whetstone Capital Advisors LLC raised its stake in shares of LifeMD, Inc. (NASDAQ:LFMD) by 89.6% in the fourth quarter, Holdings Channel.com reports. The fund owned 703,053 shares of the company’s stock after purchasing an additional 332,269 shares during the period. LifeMD makes up approximately 0.7% of Whetstone Capital Advisors LLC’s investment portfolio, making the stock its 23rd biggest position. Whetstone Capital Advisors LLC’s holdings in LifeMD were worth $2,397,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the stock. Vanguard Group Inc. increased its position in shares of LifeMD by 6.7% during the third quarter. Vanguard Group Inc. now owns 2,226,871 shares of the company’s stock valued at $15,120,000 after acquiring an additional 140,749 shares during the last quarter. Federated Hermes Inc. increased its position in shares of LifeMD by 278.1% during the fourth quarter. Federated Hermes Inc. now owns 980,285 shares of the company’s stock valued at $3,343,000 after acquiring an additional 721,018 shares during the last quarter. Geode Capital Management LLC increased its position in shares of LifeMD by 1.2% during the fourth quarter. Geode Capital Management LLC now owns 959,700 shares of the company’s stock valued at $3,273,000 after acquiring an additional 11,324 shares during the last quarter. Royce & Associates LP increased its position in shares of LifeMD by 11.7% during the fourth quarter. Royce & Associates LP now owns 909,651 shares of the company’s stock valued at $3,102,000 after acquiring an additional 95,200 shares during the last quarter. Finally, Prescott Group Capital Management L.L.C. acquired a new stake in shares of LifeMD during the fourth quarter valued at about $2,344,000. 35.52% of the stock is currently owned by institutional investors and hedge funds.

LifeMD Stock Performance

Shares of LFMD stock opened at $4.70 on Monday. The stock has a market capitalization of $227.29 million, a P/E ratio of 94.02 and a beta of 1.98. The company has a 50 day moving average price of $4.36 and a 200 day moving average price of $3.80. LifeMD, Inc. has a fifty-two week low of $2.56 and a fifty-two week high of $15.84.

LifeMD (NASDAQ:LFMD) last announced its quarterly earnings data on Wednesday, May 6th. The company reported ($0.20) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.06). The business had revenue of $50.16 million during the quarter, compared to analyst estimates of $48.84 million. LifeMD had a net margin of 2.37% and a negative return on equity of 150.88%. On average, research analysts forecast that LifeMD, Inc. will post -0.37 EPS for the current fiscal year.

Wall Street Analyst Weigh In

LFMD has been the subject of a number of recent analyst reports. Weiss Ratings upgraded shares of LifeMD from a “sell (e+)” rating to a “sell (d)” rating in a research report on Thursday, May 7th. Loop Capital set a $10.00 price target on shares of LifeMD in a research report on Thursday, March 12th. Mizuho upgraded shares of LifeMD from a “neutral” rating to an “outperform” rating and lifted their price target for the company from $6.00 to $8.00 in a research report on Monday, March 16th. Wall Street Zen cut shares of LifeMD from a “hold” rating to a “sell” rating in a research report on Saturday, May 9th. Finally, UBS Group reiterated a “buy” rating on shares of LifeMD in a research report on Wednesday, May 27th. Eight equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $9.14.

LifeMD Profile

LifeMD (NASDAQ: LFMD) is a U.S.-based telehealth company that delivers on-demand, membership-based virtual healthcare services. Through its digital platform and mobile applications, LifeMD connects patients with board-certified healthcare providers for diagnosis, treatment and ongoing management of a range of acute and chronic conditions. The company’s core offering centers on personalized care plans supported by prescription fulfillment, lab testing and prescription delivery services.

LifeMD’s service portfolio spans several specialty areas, including men’s health, hormonal therapy, weight management and primary care.